Dermatology devices market to reach $17.73 billion by 2031
The global dermatology devices market is set to nearly double from USD 9.32 billion in 2026 to USD 17.73 billion by 2031, driven by a 13.7% CAGR. Laser-based technologies lead with 37.4% share, while aesthetic applications show the highest growth potential. North America remains the largest regional market.

*this image is generated using AI for illustrative purposes only.
MarketsandMarkets has released a new report projecting the global dermatology devices market to reach USD 17.73 billion by 2031, growing from USD 9.32 billion in 2026 at a compound annual growth rate (CAGR) of 13.7%. This significant expansion reflects accelerating adoption of advanced diagnostic and therapeutic technologies across medical and aesthetic sectors worldwide. The forecast period covers 2026 to 2031, with North America identified as the leading regional market in 2025.
The market’s growth trajectory is underpinned by several key drivers, including the rising prevalence of skin disorders such as acne, psoriasis, eczema, skin cancer, and pigmentation issues. Simultaneously, there is surging global demand for aesthetic procedures, supported by growing awareness of skin health, rising disposable incomes, and an aging population seeking anti-aging and rejuvenation treatments. Patients are increasingly preferring minimally invasive and non-invasive procedures, which has boosted demand for advanced treatment technologies in hospitals, dermatology clinics, and aesthetic centers.
Market Segmentation and Technology Trends
The dermatology devices market is segmented by technology, type, application, end user, and region. In 2025, the laser-based segment held the largest market share at 37.4%, driven by its widespread use in hair removal, skin rejuvenation, scar revision, tattoo removal, and vascular lesion treatment. Treatment devices accounted for the largest share by type, holding 61.0% of the market in 2025. Aesthetic therapeutic applications are expected to grow at the highest CAGR during the forecast period.
| Segment | Category | Key Metric (2025) |
|---|---|---|
| By Type | Treatment Devices | 61.0% market share |
| By Technology | Laser-Based | 37.4% market share |
| By Region | North America | Largest market share |
| By End User | Hospitals/Clinics | Largest market share |
Technological innovations are enhancing precision and safety. Advances in laser systems, radiofrequency (RF), high-intensity focused ultrasound (HIFU), light-based therapies, and cryotherapy are improving clinical outcomes. The integration of high-resolution imaging modalities, such as optical coherence tomography (OCT) and high-frequency ultrasound (HFUS), enables earlier detection of skin disorders, reducing the need for invasive diagnostics.
Competitive Landscape and Regional Insights
North America dominated the market in 2025, benefiting from well-established healthcare infrastructure, high disposable incomes, favorable reimbursement policies, and strong patient awareness. The region also sees frequent product launches and regulatory approvals. Beauty centers are expected to be the fastest-growing end-user segment, reflecting the shift toward cosmetic dermatology.
Key players identified as star players due to their strong market presence include Bausch Health Companies Inc., Sisram Medical Ltd., AbbVie Inc., InMode Ltd., and BTL Group of Companies. Startups and SMEs such as Dimed Laser, Sciton, Fotona, Lynton Lasers Ltd., Astanza Laser, and Courage+Khazaka Electronic GmbH have secured strong footholds in specialized niche areas. Other notable companies include Alma Lasers, Cutera, Cynosure, Lumenis, Solta Medical, Bruker Corporation, Carl Zeiss, Candela Corporation, Genesis Biosystems, HEINE Optotechnik, Michelson Diagnostics, PhotoMedex, Leica Microsystems, Olympus Corporation, FotoFinder Systems, Canfield Scientific, Beijing Toplaser Technology, DermLite, Syneron Medical, Aerolase, and Bovie.
What the Numbers Show
The data indicates a structural shift toward aesthetic applications, with this segment projected to record the highest growth rate. While hospitals and clinics currently hold the largest share due to complex medical treatments, the rapid expansion of beauty centers suggests that consumer-driven cosmetic procedures are becoming a primary growth engine. The dominance of laser technology (37.4%) underscores its versatility in both medical and aesthetic contexts, positioning it as the core driver of near-term revenue expansion.
How might evolving regulatory frameworks for aesthetic procedures in key emerging markets impact the projected 13.7% CAGR of the dermatology devices sector?
What strategic advantages do established players like Bausch Health and InMode hold against agile startups such as Dimed Laser and Sciton in capturing the fastest-growing beauty center segment?
To what extent will the integration of AI-driven diagnostic imaging, such as OCT and HFUS, shift market share from traditional laser-based treatment devices to advanced diagnostic platforms by 2031?

































